Skip to main content
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. — Investor Relations & Filings

Ticker · NERV ISIN · US6033802058 LEI · 54930017PANCHC5LYH79 US Manufacturing
Filings indexed 587 across all filing types
Latest filing 2026-05-05 Interim / Quarterly Rep…
Country US United States of America
Listing US NERV

About Minerva Neurosciences, Inc.

https://www.minervaneurosciences.com/

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.

Recent filings

Filing Released Lang Actions
10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-05 English
8-K - Minerva Neurosciences, Inc. (0001598646) (Filer)
Regulatory Filings
2026-05-05 English
ARS - Minerva Neurosciences, Inc. (0001598646) (Filer)
Annual Report
2026-04-23 English
DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English
8-K - Minerva Neurosciences, Inc. (0001598646) (Filer)
Regulatory Filings
2026-04-06 English
EFFECT - Minerva Neurosciences, Inc. (0001598646) (Filer)
Regulatory Filings
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.